Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts ACXP Hot Sheet
Join SI Premium – FREE
Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Acurx gets FDA conditional brand name acceptance for CDI drug
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
